Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hugh, Zhao"'
Autor:
Justin Zhao, Ge Song, Qinghua Zhao, Hanqing Feng, Yunbing Wang, James M. Anderson, Hugh Zhao, Qing Liu
Publikováno v:
Journal of Biomedical Materials Research Part B: Applied Biomaterials. 111:656-664
With the ripening of 3D printing technology and the discovery of a variety of printable materials, 3D-printed vascular stents provide new treatment options for patients with angiocardiopathy. Bioresorbable stent not only combines the advantages of me
Autor:
Mark W. Holladay, Shripad S. Bhagwat, Michael Williams, Bruce D. Dorsey, Raffaella Faraoni, Julius L. Apuy, Mark A. Ator, Darren E. Insko, Mehran Yazdanian, Dana Gitnick, Mangeng Cheng, Ronald R. Nepomuceno, Kathryn Hunter, Merryl D. Cramer, Hugh Zhao, Michael F. Gardner, Pawel Dobrzanski, Ruwanthi N. Gunawardane, Susan Jones-Bolin, Martin W. Rowbottom, Robert C. Armstrong, Bruce Ruggeri, Joyce James
PDF file - 74K, CEP-32496 Supplemental Data.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e595ddea4dcb7e0d0c551afc2da871ae
https://doi.org/10.1158/1535-7163.22498993.v1
https://doi.org/10.1158/1535-7163.22498993.v1
Autor:
Greg L. Kaluza, Krzysztof Milewski, Alexander Nikanorov, Juan F. Granada, John Stankus, Christian G. Krueger, Renu Virmani, Armando Tellez, Hugh Zhao, Michael S. Aboodi, Lewis B. Schwartz
Publikováno v:
Circulation: Cardiovascular Interventions. 4:447-455
Background— Drug-coated balloons are rapidly emerging as a therapeutic alternative for the interventional treatment of peripheral vascular disease. The purpose of this study was to test the hypothesis that an angioplasty balloon coated with the mTO
Late Stent Expansion and Neointimal Proliferation of Oversized Nitinol Stents in Peripheral Arteries
Autor:
Russell S. Jones, Hugh Zhao, Lewis B. Schwartz, Alexander Nikanorov, Erica Pacheco, Renu Virmani
Publikováno v:
CardioVascular and Interventional Radiology. 32:720-726
For peripheral endovascular intervention, self-expanding (SE) stents are commonly oversized in relation to target arteries to assure optimal wall apposition and prevent migration. However, the consequences of oversizing have not been well studied. Th
Autor:
Sandra J. Hoffman, Maxine Gowen, Daniel P. Nadeau, Sabine Rehm, Mark Nuttall, Bradbeer Jeremy N, George B. Stroup, Hugh Zhao
Publikováno v:
Endocrinology. 139:5224-5234
Idoxifene, a novel selective estrogen receptor modulator, was tested for its effects on bone loss, serum cholesterol, and uterine wet weight and histology in the ovariectomized (Ovx) rat. Idoxifene (0.5 mg/kg x day) completely prevented loss of both
Autor:
Jeremy N. Bradbeer, Rasesh D. Kapadia, George B. Stroup, Susanta K. Sarkar, Alison M. Badger, Barbara A. Swift, Hugh Zhao, David J. Rieman
Publikováno v:
Arthritis & Rheumatism. 39:504-514
Objective. To evaluate the effect of SK&F 106615 on joint integrity in rats with adjuvant-induced arthritis (AIA). Methods. AIA was induced in Lewis rats on day 0, and the animals were treated either prophylactically (days 0–16 or days 0–23) or t
Autor:
Mangeng Cheng, Kathryn Hunter, Bruce D. Dorsey, Bruce Ruggeri, Dana Gitnick, Martin W. Rowbottom, Pawel Dobrzanski, Michael Williams, Darren E. Insko, Michael F. Gardner, Merryl Cramer, Ruwanthi N. Gunawardane, Susan Jones-Bolin, Mehran Yazdanian, Raffaella Faraoni, Julius L. Apuy, Shripad S. Bhagwat, Mark W. Holladay, Robert C. Armstrong, Hugh Zhao, Joyce James, Ronald R. Nepomuceno, Mark A. Ator
Publikováno v:
Molecular cancer therapeutics. 11(4)
Mutations in the BRAF gene have been identified in approximately 7% of cancers, including 60% to 70% of melanomas, 29% to 83% of papillary thyroid carcinomas, 4% to 16% colorectal cancers, and a lesser extent in serous ovarian and non–small cell lu
Autor:
Nadine C. Becknell, Thelma S. Angeles, Edward R. Bacon, Hugh Zhao, Lisa D. Aimone, Sheila J. Miknyoczki, John P. Mallamo, Susan Jones-Bolin, Mark S. Albom, Hong Chang, Robert L. Hudkins, Allison L. Zulli, Mark A. Ator, Bruce Ruggeri, Kathryn Hunter, Ted L. Underiner
Publikováno v:
Journal of medicinal chemistry. 55(2)
A substantial body of evidence supports the utility of antiangiogenesis inhibitors as a strategy to block or attenuate tumor-induced angiogenesis and inhibition of primary and metastatic tumor growth in a variety of solid and hematopoietic tumors. Gi
Publikováno v:
Journal of Vascular Surgery. 49(5)